ישראל - עברית - Ministry of Health

biotis ltd - prucalopride as succinate - טבליות מצופות פילם - prucalopride as succinate 2 mg - prucalopride - prucalopride - resolor is indicated for symptomatic treatment of chronic constipation in women in whom laxatives fail to provide adequate relief

ישראל - עברית - Ministry of Health

teva israel ltd - bisacodyl - טבליות מצופות פילם - bisacodyl 5 mg - bisacodyl - bisacodyl - all types of constipation in ambulatory and bedridden in patients over the age of 6 years . preparation of patients for abdominal radiography and proctoscopy.

ישראל - עברית - Ministry of Health

cts chemical industries ltd, israel - bisacodyl - טבליות עם ציפוי אנטרי - bisacodyl 5 mg - bisacodyl - bisacodyl - all types of constipation in ambulatory and bedridden patients over the age of 6 years. preparation of patients for abdominal radiography and proctoscopy.

ישראל - עברית - Ministry of Health

tradis gat ltd - mesalazine - טבליות עם ציפוי אנטרי - mesalazine 400 mg - mesalazine - mesalazine - maintenance of remission in ulcerative colitis and for treatment of acute episodes in crohn's disease.

ישראל - עברית - Ministry of Health

tradis gat ltd - mesalazine - טבליות עם ציפוי אנטרי - mesalazine 800 mg - mesalazine - mesalazine - maintenance of remission in ulcerative colitis and for treatment of acute episodes in crohn's disease.

ישראל - עברית - Ministry of Health

trima israel pharmaceutical products maabarot ltd - ox bile extract; pancreatin - דרז'ה - pancreatin 72 mg; ox bile extract 35 mg - multienzymes and acid preparations - multienzymes and acid preparations - regulation of digestive disturbances, indigestion fermentative dyspepsia, gastroenteritis, meteorism, epigastric fullness and post prandial distress.

ישראל - עברית - Ministry of Health

sanofi israel ltd - clopidogrel as hydrogen sulfate - טבליות מצופות פילם - clopidogrel as hydrogen sulfate 75 mg - clopidogrel - clopidogrel - prevention of atherotrobmotic eventsclopidogrel is indicated in :• adult patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.• adult patients suffering from acute coronary syndrome- non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave myocardial infarction (mi)), including patients undergoing a stent placement following percutaneous coronary intervention, in combination with acetylsalicylic acid (asa). - st segment elevation acute myocardial infarction, in combination with asa in medically treated patients eligible for thrombolytic therapyprevention of atherotrobmotic and thromboembolic events in atrial fibrillation: in adult patients with atrial fibrillation who have at least one risk factor for vascular events, are not suitable for the treatment with vitamin k antagonists (vka) anti-thrombin or anti factor xa, and who have a low bleeding risk, clopid

ישראל - עברית - Ministry of Health

dexcel pharma technologies ltd - clopidogrel as besylate - טבליות מצופות פילם - clopidogrel as besylate 75 mg - clopidogrel - clopidogrel - clopidogrel is indicated for the prevention of atherothrombotic events as follows:• recent mi, recent stroke or established peripheral arterial disease: patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease. for patients with a history of recent myocardial infarction (mi), recent stroke or established peripheral arterial disease, clopidogrel has been shown to reduce the rate of a combined endpoint of new ischemic stroke (fatal or not), new mi (fatal or not) and other vascular death.• acute coronary syndrome: for patients with acute coronary syndrome (non-st segment elevation acute coronary syndrome (unstable angina/non-q-wave mi) or st segment elevation acute myocardial infarction), in combination with asa in medically treated patients eligible for thrombolytic therapy, and those who are to be managed with percutaneous coronary intervention (with or without stent) or cabg clopi

ישראל - עברית - Ministry of Health

dexcel ltd, israel - acetylsalicylic acid - טבליות עם ציפוי אנטרי - acetylsalicylic acid 75 mg - acetylsalicylic acid - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.

ישראל - עברית - Ministry of Health

dexcel ltd, israel - acetylsalicylic acid - טבליות עם ציפוי אנטרי - acetylsalicylic acid 100 mg - acetylsalicylic acid - acetylsalicylic acid - the primary prevention of coronary heart disease in patients at increased risk and the secondary prevention of thrombotic cerebrovascular or cardiovascular disease.